b5media.com

Advertise with us

Enjoying this blog? Check out the rest of the Health & Wellness Channel Subscribe to this Feed

Cancer Commentary - Caring About Cancer

December 21st, 2006

Velcade+ Doxil: Better than Velcade Alone in Slowing Progression of Multiple Myloma

In a phase II trial led by a University of North Carolina at Chapel Hill School of Medicine researcher found that a newly formulated chemotherapy drug Doxil (doxorubicin delivered via liposomes, or microscopic fat bubbles) combined with standard therapy Velcade slows the progression of multiple myeloma better than Velcade alone.
Multiple myeloma is an advanced cancer […]

By Gloria Gamat -- 0 comments